相似文献
1
A 75-year-old man with progressive bronchioalveolar carcinoma.一名患有进行性细支气管肺泡癌的75岁男性。
Semin Oncol. 2013 Feb;40(1):e1-8. doi: 10.1053/j.seminoncol.2012.11.004.
2
[Importance of pathology research on lung adenocarcinoma].
Zhonghua Bing Li Xue Za Zhi. 2012 Oct;41(10):649-51. doi: 10.3760/cma.j.issn.0529-5807.2012.10.001.
3
Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations.伴有胚系表皮生长因子受体T790M突变的肿瘤中的并发分子改变。
Clin Lung Cancer. 2013 Jul;14(4):452-6. doi: 10.1016/j.cllc.2013.01.005. Epub 2013 Mar 26.
4
Bronchioloalveolar adenocarcinoma and pulmonary langerhans cell histiocytosis in a patient with MUTYH-associated polyposis.一名患有MUTYH相关息肉病的患者出现细支气管肺泡腺癌和肺朗格汉斯细胞组织细胞增多症。
J Clin Oncol. 2011 Mar 10;29(8):e188-90. doi: 10.1200/JCO.2010.32.1026. Epub 2010 Dec 28.
5
Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief report.索拉非尼用于携带K-ras突变的晚期非小细胞肺癌患者：简要报告
J Thorac Oncol. 2010 May;5(5):719-20. doi: 10.1097/JTO.0b013e3181d86ebf.
6
Mucinous bronchioloalveolar carcinoma with K-ras mutation arising in type 1 congenital cystic adenomatoid malformation: a case report with review of the literature.1型先天性囊性腺瘤样畸形中发生的伴有K-ras突变的黏液性细支气管肺泡癌：一例报告并文献复习
Int J Clin Exp Pathol. 2013 Oct 15;6(11):2597-602. eCollection 2013.
7
Histology matters: individualizing treatment in non-small cell lung cancer.组织学很重要：个体化治疗非小细胞肺癌。
Oncologist. 2010;15(1):3-5. doi: 10.1634/theoncologist.2009-0306. Epub 2010 Jan 19.
8
Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of the lung with bronchioloalveolar features?有哪些与具有细支气管肺泡特征的肺腺癌患者的表皮生长因子受体和 KRAS 突变相关的影像学特征？
J Thorac Oncol. 2010 Mar;5(3):344-8. doi: 10.1097/JTO.0b013e3181ce9a7a.
9
Bronchioloalveolar neoplasia.细支气管肺泡瘤变
Int J Clin Exp Pathol. 2010 Nov 12;4(1):97-9.
10
Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis.肺多形性癌：一项包括 EGFR 突变分析的临床病理研究。
J Thorac Oncol. 2010 Apr;5(4):460-5. doi: 10.1097/JTO.0b013e3181ce3e3c.
本文引用的文献
1
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.新型组织学国际肺癌研究协会/美国胸科学会/欧洲呼吸学会肺腺癌分类系统是一种与分期无关的生存预测指标。
J Clin Oncol. 2012 May 1;30(13):1438-46. doi: 10.1200/JCO.2011.37.2185. Epub 2012 Mar 5.
2
Prognostic patterns in the histopathology of pulmonary adenocarcinoma.肺腺癌组织病理学中的预后模式。
J Clin Oncol. 2012 May 1;30(13):1401-3. doi: 10.1200/JCO.2011.40.3964. Epub 2012 Mar 5.
3
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome.KRAS 癌基因取代对蛋白质行为的影响：对信号转导和临床结果的影响。
J Natl Cancer Inst. 2012 Feb 8;104(3):228-39. doi: 10.1093/jnci/djr523. Epub 2012 Jan 13.
4
High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.韩国男性吸烟肺腺癌患者中 EGFR 突变的高发率：与组织学亚型、EGFR/TTF-1 表达及临床特征的相关性，无肿瘤内异质性。
J Thorac Oncol. 2012 Feb;7(2):323-30. doi: 10.1097/JTO.0b013e3182381515.
5
Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer.一项随机、安慰剂对照的厄洛替尼维持治疗晚期非小细胞肺癌的前瞻性分子标志物分析：EGFR 和 KRAS。
J Clin Oncol. 2011 Nov 1;29(31):4113-20. doi: 10.1200/JCO.2010.31.8162. Epub 2011 Oct 3.
6
A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations.一项在携带 KRAS 突变的肺腺癌患者中进行的 Salirasib Ⅱ期临床试验。
J Thorac Oncol. 2011 Aug;6(8):1435-7. doi: 10.1097/JTO.0b013e318223c099.
7
Combination chemotherapy for older adults with advanced non-small-cell lung cancer.老年晚期非小细胞肺癌的联合化疗
Lancet. 2011 Sep 17;378(9796):1055-7. doi: 10.1016/S0140-6736(11)61259-2. Epub 2011 Aug 8.
8
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.卡铂和每周紫杉醇联合化疗与单药治疗老年晚期非小细胞肺癌的比较：IFCT-0501 随机、3 期试验。
Lancet. 2011 Sep 17;378(9796):1079-88. doi: 10.1016/S0140-6736(11)60780-0. Epub 2011 Aug 8.
9
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.癌症统计数据，2011 年：消除社会经济和种族差异对癌症过早死亡的影响。
CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. doi: 10.3322/caac.20121. Epub 2011 Jun 17.
10
Cetuximab for the treatment of advanced bronchioloalveolar carcinoma (BAC): an Eastern Cooperative Oncology Group phase II study (ECOG 1504).西妥昔单抗治疗晚期细支气管肺泡癌（BAC）：东部肿瘤协作组 II 期研究（ECOG 1504）。
J Clin Oncol. 2011 May 1;29(13):1709-14. doi: 10.1200/JCO.2010.33.4094. Epub 2011 Mar 21.
Zotero 插件